首页> 外文期刊>Cardiovascular journal of Africa. >Is double-blinding possible while administering fluids in the intensive care unit?
【24h】

Is double-blinding possible while administering fluids in the intensive care unit?

机译:在重症监护室中输液时是否可能出现双盲现象?

获取原文
获取原文并翻译 | 示例
           

摘要

The publication by Alavi SM et al. highlights a subject with an ongoing debate, namely the 'crsytalloid-colloid and colloid-colloid use following cardiac surgery'.1 They designed a randomised, double-blind clinical trial and compared the effects of three different solutions; 0.9% Ringer's lactate, 4% gelatin and 6% hydroxyethyl starch (HES) solution. They concluded that the HES solution was better in terms of the volume-expanding effect; lower amounts were required compared to the other two solutions, and short-term renal functions were better. We feel that there are several insufficiencies about the design and contents of the study. We believe that the process of double-blinding is quite challenging in this study, because the anesthesiologist or intensivist should be unaware of the solution administered. The process of double-blinding and how un-blinding was avoided should be detailed.
机译:Alavi SM等人的出版物。重点突出了一个有争议的话题,即“心脏手术后使用类晶体胶体和胶体胶体”。1他们设计了一项随机,双盲临床试验,并比较了三种不同解决方案的效果; 0.9%的林格氏乳酸,4%的明胶和6%的羟乙基淀粉(HES)溶液。他们得出结论,就体积扩大效果而言,HES解决方案更好。与其他两种解决方案相比,所需量更少,并且短期肾功能更好。我们认为研究的设计和内容存在一些不足。我们认为,在本研究中,双盲治疗的过程非常具有挑战性,因为麻醉师或强化医生应该不知道所用的溶液。应该详细说明双盲的过程以及如何避免脱盲。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号